Article
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
Journal of clinical immunology - 1 Feb 2022
Fong Siew-Wai, Yeo Nicholas Kim-Wah, Chan Yi-Hao, Goh Yun Shan, Amrun Siti Naqiah, Ang Nicholas, Rajapakse Menaka Priyadharsani, Lum Josephine, Foo Shihui, Lee Cheryl Yi-Pin, Carissimo Guillaume, Chee Rhonda Sin-Ling, Torres-Ruesta Anthony, Tay Matthew Zirui, Chang Zi Wei, Poh Chek Meng, Young Barnaby Edward, Tambyah Paul A, Kalimuddin Shirin, Leo Yee-Sin, Lye David C, Lee Bernett, Biswas Subhra, Howland Shanshan Wu, Renia Laurent, Ng Lisa F P
Abstract excerpt
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) that have become dominant as the pandemic progresses bear the ORF8 mutation together with multiple spike mutations. A 382-nucleotide deletion (Δ382) in the ORF7b and ORF8 regions has been associated with milder disease phenotype and less systemic inflammation in COVID-19 patients. However, its impact on host immunity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
